Vaccinating glycopeptidic antigenic fraction with a very high le

Details Vaccinating glycopeptidic antigenic fraction with a very high le Vaccinating glycopeptidic antigenic fraction with a very high le

1980-06-26

1983-09-06

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

424177, 424180, 424 88, A61K 3902, A61K 3702

Patent

active

044029390

ABSTRACT:
A glycopeptic vaccinating antigenic fraction with a very high level of immunogenicity, which is isolated from a culture of pathogenic germs comprises an osidic part present in a proportion of about 50%, with a proteinic part, which are linked together by covalent bond; when it is opposed to a suitable immune-serum, the fraction has an immunological image which essentially comprises a `clear` line of precipitation close to the antigen pit, in immunodiffusion in gelose. The fraction is used for the preparation of vaccines and as a diagnostic agent.

REFERENCES:
patent: 3342684 (1967-09-01), Lembke et al.
patent: 3395219 (1968-07-01), Millman
patent: 3855197 (1974-12-01), Hirsch et al.
patent: 3929994 (1975-12-01), Hirsch et al.
patent: 4010257 (1977-03-01), Adlam et al.
patent: 4069314 (1978-01-01), Adlam et al.
patent: 4123520 (1978-11-01), Hagopian et al.
patent: 4203970 (1980-05-01), Carlo et al.
Chemical Abstracts, vol. 74, p. 255, Abst. No. 85782g, 1971.
Nogel, J., "Isolation from Bordetella Pertussis of Proctective Additive Free from Toxic Activity and Histomine Sensitizing Factor", Nature, vol. 214, Apr. 1, 1967, pp. 96-97.
Van Hemert, P., "Preparation of Soluble Pertussis Vaccine", Nature, vol. 203, Aug. 15, 1964, 774-775.
Chemical Abstracts, vol. 69, No. 21, Ref. 85020d, p. 7940, 11/19/68 of Pasztai, Z, Ann. Immunol. Hung, 1967, 10.55-62.
Microbiology Abstracts, vol. 6, No. 5, Feb. 1971, Section B, Ref. B3786 of Orr et al., Infect. Immunity, 2, 543-548 (1970).
Chemical Abstracts, vol. 67, p. 160, Abst. No. 1776c, 1967.
Chemical Asbtracts, vol. 58, Abst. No. 14577c, 1963.

Affiliated with

Also associated with

Rating

Vaccinating glycopeptidic antigenic fraction with a very high le does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccinating glycopeptidic antigenic fraction with a very high le, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccinating glycopeptidic antigenic fraction with a very high le will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1592098